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Abstract  
To examine the template-switching technology accompanied by in vitro transcription (the Switch Mechanism At the 5ʹ 
end of Reverse Transcript) to amplify enough amount of mRNA as input for gene expression experiments. We amplified 
limited quantity of esophageal squamous cell carcinoma (ESCC) transcripts samples using generated ds cDNA as 
template and in vitro transcription (IVT) reaction. In addition, the quality and quantity of amplified mRNA were 
assessed by comparative real-time PCR of genes such as stem cell markers CD44, OCT4 and SNAIL as well as 
MAGE-A4 as a cancer-testis antigens, and XRCC5 as an underexpressed gene in ESCC. 
The results obtained from this study demonstrated that optimal amounts of mRNA are generated by template-switching 
and IVT reaction. Integrity and purity of all RNA samples were assessed. By using this approach, over 10 micrograms of 
amplified mRNA were generated from 100 ng of starting total RNA. The results of comparative real-time PCR of five 
genes with different levels of expression illustrated that the expression level of amplified sense RNA was almost similar 
when compared with non-amplified RNA. Our results clearly showed the usefulness of the T7-based IVT technique for 
amplification of limited quantity of input total RNA. 
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Introduction 
Identifying differentially expressed genes have emerged as a vital point for understanding the complex 
molecular mechanisms including cell growth, progression, differentiation and tumorigenesis and gene 
regulatory pathways. Evaluation of transcriptome profiling is a valuable tool to identify novel and key 
biomarkers involved in the biological procedure. There are numerous technologies available for 
characterization of differential gene expression. These technologies include microarray, RT-PCR, northern 
blot, serial analysis of gene expression (SAGE), massively parallel signature sequencing (MAPS), 
differential display RT-PCR, and subtractive hybridization[1, 2]. Investigation of the gene profiling, as well 
as recognizing key markers in diagnosis, prognosis, progression and  treatment of diseases, and all 
processes that lead to disease development require considerable amount of input RNA for transcript profiling 
analysis[3, 4]. Unfortunately, many of the specimens obtained from procedures such as laser capture 
microdissection, cell sorting, or biopsy samples are limited to a small-scale of tissue; for this reason, RNA 
obtained from clinical samples are a finite amount with low yield[5]. Several techniques are available for 
RNA amplification, but it is remarkable that in all these methods, no changes in the expression levels of 
genes should occur following amplification. Enrichment and amplification of limited amount of RNA should 
not change primary function of the RNA[6]. Most of mRNA amplification techniques are based on  in vitro 
transcription (IVT) mechanism using the minimal quantities of RNA as starting sample[7]. The combination 
of template-switching (Switch Mechanism At the 5ʹ end of Reverse Transcript) technology with T7 RNA 
polymerase transcription is applied as one of the methods of RNA amplification. In this RNA amplification 
procedure, microgram amounts of mRNA have been obtained from nanogram or picogram quantities of total 
RNA. To amplify the extra amounts of mRNA, the RNA obtained from the IVT reaction is generated using 
second strand cDNA (ds cDNA) as template. Primary step for amplifying the transcriptome, the full-length 
single strand cDNA (ss cDNA), is generated through two oligonucleotide primers. First, a modified oligo 
(dT) primer (CDSIIA) is applied for ss cDNA synthesis, which is complementary to the SMART T7 
oligonucleotide primer. Afterward, SMART T7 anchored to ss cDNA plus RNase H and DNA polymerase is 
applied to produce the ds cDNA with high quality. Eventually, linear sense RNA is amplified using T7 RNA 
polymerase and the ds cDNA template[8-10]. It is important to recognize that in the SMART amplification, 
what can change the expression level of genes after amplification of sample RNA. Because it is essential in 
further analysis, relative expression levels of individual genes after amplification should be similar to the 
original RNA level [11].  
In the present study, we assessed that weather in vitro transcription reaction can generate sufficient amplified 
sense RNA from the finite amounts of total RNA via the application of the SMART methodology. 
Meanwhile, we comparatively studied the gene expression of known genes before and after RNA 
amplification of specimens. By using real-time RT-PCR as a comparative gene expression technique, the 
expression levels of mRNA in human esophageal squamous cell carcinoma (ESCC) tissue samples can be 
investigated. 
Materials and Methods 
Study population and sample collection 
The human fresh tumoral and distant tumor-free tissues were collected from five patients with ESCC as RNA 
source through esophagectomies at Omid Oncology Hospital of Mashhad University of Medical Sciences 
(MUMS), Mashhad, Iran. None of the patients received therapeutic procedure such as chemo- or 
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radiotherapy prior to surgery. The specimens were immediately transferred to RNAlater solution (Qiagen, 
Hilden, Germany) after esophagectomy and stored in -20⁰ C.  All samples histologically contained at least 
70% tumor cells. The study was approved by the Ethics Committee of the MUMS. 
 
Total RNA preparation 
Total RNA was isolated from the five tissue samples by RNeasy kit (Qiagen, Hilden, Germany) according to 
the manufacturer's instructions. The concentration and purity of extracted total RNAs was evaluated using 
the NanoDrop spectrophotometer based on the recommendations of the manufacturer, and also the 
absorbance ratios (A260/280) of 1.8 to 2.0. Additionally, the integrity of RNA was confirmed by illustration 
of perfect 28S and 18S ribosomal bands following electrophoresis on agarose gel. 
 
SMART method 
SMART –step 1. To synthesize first-strand cDNA, a mixture reaction containing 200 ng of total RNA 
prepared from normal or tumoral tissues of ESCC samples as a template that was combined with 1 μl of 12 
μM cDNA synthesis (CDS) primer II A and deionized water for a final volume of 4.75 μl. Specific 
oligonucleotide sequences are listed in Table 1. The solution was heated at 70⁰ C for 5 min and then 
snap-cooled on ice. Then the reaction was followed by the addition of 2 μl 5X first-strand buffer (Thermo 
Scientifc, USA), 0.5 μl of 100 mM dithiothreitol (DTT), 0.25 μl of 40 U/μl Ribolock RNase inhibitor 
(Thermo Scientifc, USA), 1 μl of 10 μM SMART T7 oligonucleotide, 1 μl of 10 mM dNTP (Pars tous, Iran) 
and 1 μl of 2000 U/μl Maxima H Minus Reverse Transcriptase (Thermo Scientifc, USA) to the RNA solution. 
Afterward, temperature was adjusted at 37˚C for 2 hours to start the first-strand cDNA synthesis, followed by 
terminating the reaction at 68˚C for 10 min.  
SMART –step 2. For the synthesis of double-strand cDNA, the second strand was synthesized in a total 
volume of 100 μl reaction mixture including 73 μl deionized water, 10 μl of 10X PCR buffer (Pars tous, Iran), 
2 μl of 10 mM 50 X dNTPs mix, 2 μl of 10 μM T7 extension primer  (Table 1), 2 μl of 5 U/μl RNase H 
(BioLab, England) and 2 μl Taq DNA polymerase (Pars tous, Iran) were added to the first-strand cDNA 
sample. The solution was incubated at 37˚C for 15 min, 95˚C for 5 min, 59 ˚C for 1 min and 72˚C for 15 
min. 
 
Table 1 Oligonucleotides sequences used for ss cDNA and ds cDNA synthesis 
 
Oligonucleotides Sequence (5'→3') 
cDNA synthesis (CDS) primer II A AAGCAGTGGTATCAACGCAGAGTACT(30) VN 
SMART T7 Oligonucleotide ACTCTAATACGACTCACTATAGGGAGAGGGCGGG 
T7 Extension Primer GCTCTAATACGACTCACTATAGG 
(N = A, C, G, or T; V = A, G, or C) 
 
SMART –step 3. To purify double-stranded cDNA, the obtained ds cDNA was purified by PCR cleanup kit 
(Qiagen, Hilden, Germany) according to the user manual. Finally, the sample eluted in 12 μl deionized water. 
Then 2.5 volume of (30 μl) 100% ethanol, 0.1 volume of (1.2 μl) sodium acetate (3 M) and 2 μl glycogen 
were added and the sample placed in a -20˚C freezer for overnight to precipitate the cDNA. The obtained 
cDNA pellets were rinsed with 70% ethanol, dried, and then precipitated cDNA was resuspended in 10 μl 
RNase-free water. 
SMART –step 4. To synthesize mRNA by T7 in vitro transcription, the T7 transcription kit (Jena Bioscience, 
Germany) was used. In brief, the purified double-strand cDNA solutions were added to a mixture reaction 
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including 4 μl of T7 reaction buffer, 1 μl of NTP mix, 0.2 μl of 40 U/μl RNase inhibitor and 0.2 μl of 200 
U/μl T7 RNA polymerase in a 20 μl reaction volume that filled up with water. The solution was incubated at 
37˚C for 12 hr. 
SMART –step 5. The synthesized mRNA was purified using 2.5 volume of 100% ethanol, 0.1 volumes of 
sodium acetate (3 M) and 2 μl glycogen, and the sample placed in a -20˚C freezer for overnight to precipitate 
the mRNA. The obtained pellets were washed with 70% ethanol and reaction pellet was diluted in 10 μl 
RNase-free water. 
 
Electrophoresis of mRNA synthesized by the SMART method  
To confirm the synthesis of mRNA, electrophoresis was performed on 1.2% agarose gel at 100 V for 30 min. 
Also, the concentration of the mRNA was determined using the NanoDrop spectrophotometer.   
 
RT-PCR 
The quality of amplified mRNA was determined by using three housekeeping genes including Glyceraldehyd 
3-phosphat dehydrogenase (GAPDH), β actin and β2 microglobulin as positive control.  
 
Real-time PCR 
Amplification and relative expression ratios of synthesized RNA were confirmed by gene expression of the 
primer pairs using real-time RT-PCR. The primers were designed by AlleleID software 6.0 (PREMIER 
Biosoft, CA, USA). Specific primer sequence of the selected genes and PCR product sizes are listed in Table 
2. Approximately 500 ng of RNA was used for the reverse transcription-polymerase chain reaction (RT-PCR) 
to obtain first-strand cDNA derived from RNA with oligodT primer using first-strand synthesis kit 
(Fermentas, Lithuania) in 20 µl reactions according to the manufacture’s protocol. Each experiment was 
carried out in triplicate and repeated twice for each gene by using SYBR-Green method (Ampliqune, 
Denmark) in a Stratagene Mx3000P thermocycler (Stratagene, La Jolla, CA). Expression of GAPDH as an 
endogenous control was used to normalize the data. Based on previous studies, we selected several genes 
including MAGE-A4 (Melanoma-associated antigen 4), OCT4 ( -binding 4), 
SNAIL (snail family zinc finger 1), XRCC5 (X-ray repair complementing defective repair in Chinese 
hamster cells 5), and CD44, that had shown different expression levels in the esophageal tissue [2, 12-15]. 
 
The following thermal cycling program for OCT4 and SNAIL were 10 min at 95˚C, followed by 40 cycles 
each of 95˚C for 30 sec, 59˚C for 30 sec, and 72˚C for 30 sec. The thermal profile for CD44S included 10 
min at 95°C as initial denaturation step, followed by 40 cycles of 15 sec at 95°C, 60 sec at 60°C, and finally 
45 sec at 72°C. Thermal profile for MAGE-A4gene was applied as initial denaturation step 10 min at 95 °C, 
followed by 40 cycles of 15 sec in 95 °C, 30 sec at 60 °C and finally 72 °C for 45 sec. The subsequent 
thermal cycling program for XRCC5 gene was 3 min at 50°C, then 10 min at 95°C as initial denaturation 
step, followed by 40 cycles of 15 sec at 95°C, 10 sec at 60°C, and 72°C for 20 sec. The mRNA expression 
was compared in the non- amplified sample and same amplified sample. 
 
 
 
 
Table 2 The genes and primer set sequences used for real-time PCR 
Size of PCR products (bp)  primer sequence (5'→3') Primer 
101 F: GGAAGGTGAAGGTCGGAGTCA GAPDH 
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R: GTCATTGATGGCAACAATATCCACT 
 
118 
F: ATGCCGCGCTCTTTCC 
R: TCAGCGGGGACATCCTG 
 
SNAIL 
148 
F: CCTGAAGCAGAAGAGGATCA 
R: CCGCAGCTTACACATGTTCT 
 
OCT4 
83 
F: TCCAACACCTCCCAGTATGACA 
R: GGCAGGTCTGTGACTGATGTACA 
 
CD44 
247 
F: GCTTTTCCTCATATCAAGCATAACT 
R: AATCTCTGAAATCGAGGATTTGG 
 
XRCC5 
184 
F: AGAGCTACGAGCTGCCTGAC 
R: AGCACTGTGTTGGCGTACAG  
 
 βactin 
170 
F: GGCACAACAGGTAGTAGGCG 
R: GCCACAGGAGCTTCTGACAC 
β 2 microglobulin 
 
Results  
Assessment of quality of obtained RNAs  
Briefly, total RNA was extracted from the tissue samples of patients with esophageal cancer, and then using 
electrophoresis and the measurement of absorbance, the quality of total RNA was estimated. The 260/280 nm 
absorbance ratio was generally in the range of 1.8 to 2 for total RNA that indicates the purity of the RNA. 
Moreover, RNA concentration was calculated using the Beer-Lambert law and the absorbance of RNA 
sample at 260 nm. In addition, by electrophoresis on 1.2% agarose gel the bands of 18S and 28S ribosomal 
RNA was confirmed for investigating the integrity of total RNA. Both integrity and purity of total RNA were 
appropriate for performing IVT reaction. Moreover, amplified mRNA was detected by electrophoresis on 
1.2% agarose gel. In this experiment, we used 100 ng of starting total RNA sample in SMART amplification 
for 12 hours to obtain additional quantity of mRNA. The results displayed that the size of sense amplified 
RNA ranged between ~ 0.2 to 3.0 kb (data not shown). In addition, the ratios of absorbance for mRNA 
obtained at 260/280 nm were ~ 2.0 that is accepted for purity of generated mRNA.  
 
Correlation between the quantity of starting samples and RNA obtained from T7 in vitro transcription 
The aim of this research was to examine the mRNA amplification method for generating large amount of 
mRNA. The method utilized was based on template-switching. Accordingly, tight controls of all steps were 
required to determine the applicability of T7-based SMART amplification procedure. 
There is correlation between the starting amounts of RNA for in vitro transcription (IVT) and amplified RNA. 
Reaction of IVT was carried out using 100, 1000 and 5000 ng of total RNA as the initiating specimen. As 
shown in Table 3, IVT reaction was performed for 12 hour. The mRNA was amplified from 100 ng of total 
RNA when IVT reaction was performed for 12h. The yield of RNA obtained from IVT depends on the 
amount and purity of starting RNA template. The results showed that there is a direct association between the 
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amount of primary and obtained RNA. 
 
Table 3 Quantity of mRNA amplified in IVT reaction 
Quantity of starting 
 samples (ng) 
Quantity of obtained mRNA by in vitro 
transcription (12 h) 
100 12000 ng 
1000 18000 ng 
5000 22000 ng 
 
 
Detection of synthesized mRNA  
First, the target amplified mRNA was assessed by RT-PCR with the expression of three housekeeping genes. 
After total RNA extraction and mRNA amplification, 500 ng samples were reverse transcribed for cDNA 
synthesis to evaluate the presence of GAPDH, β actin and β2 microglobulin genes by RT-PCR. The presence 
of these genes was confirmed by RT-PCR in both samples through the size of amplicons that were illustrated 
on agarose gels.  
As the second step for confirming the change in gene expression by the SMART method, the comparative 
real-time PCR of CD44, MAGE-A4, SNAIL, OCT4 and XRCC5 genes was performed using RNA obtained 
before and after amplification. The expression levels in amplified and non-amplified RNA were compared 
together as shown in Figure 1. The results of relative expression ratios of the examined genes, before and 
after amplification, were similar. 
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Figure1 Examination of change in the comparative gene expression by the SMART mRNA amplification in shown. 
 
Discussion  
Various clinical researches have required plenty amounts of RNA from limited amount of biological samples 
to perform analysis of gene expression. Therefore, it is crucial that the fidelity of amplified RNA in great 
demand is preserved to the expression profiles of total primary RNA. There are numerous methods that can 
amplify the scant amount of total RNA or mRNA for subsequent important applications. The signal and 
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global mRNA amplification are two principal ways for RNA amplification. Both of in vitro transcription and 
PCR amplification were introduced as two different procedures of global mRNA amplification, which differ 
based on basic mechanisms of generation of ds cDNA as a template. Generation of ds cDNA via a 
switch-template mechanism at 5' end of the transcript can reserve the original amplified RNA versus total 
RNA. The production of ds cDNA is introduced as an essential step in RNA amplification. Sense and 
antisense orientation in which the obtained RNA can be employed in gene expression approaches are among 
different methods of linear RNA amplification. Both of these methods can increase the number of transcripts 
from an insignificant starting quantity. Applications of antisense RNA include gene expression profiling, 
cDNA microarray and cDNA library construction as well as downstream proteomic applications. However 
every method has some obstacles, as antisense RNA cannot be used for hybridization with reverse 
transcription labeling approaches. The sense RNA can be applied for microarray analysis of gene expression. 
cDNA synthesis from amplified sense RNA can be applied as a hybridization target for any analysis with a 
sense-strand trend such as oligo microarray[4, 8, 16-18]. The present study has evaluated the technique of 
amplified sense RNA, in order to generate the high quantity of mRNA from finite amounts of tissue RNA 
available as starting sample. Here, sense RNA amplification was performed based on the switch-template 
and linear T7 in vitro transcription. In vitro transcription is an approach that synthesizes mRNA sequences 
with any quantities, and it has been used in techniques such as hybridization analysis, analysis of 
RNA-proteins binding, or as functional molecules[19]. IVT by using ds cDNA as a source template for 
amplification is introduced as an efficient approach for amplification of mRNA sequences[10]. We can 
utilize both total RNA and mRNA as starting sample for IVT reaction. 
 The quantity and quality of the starting RNA are variable and strongly rely on separation and purification 
techniques of RNA. High quality RNA isolation is among the critical steps for downstream genetic 
analysis[20, 21]. We used the quantity of less than 100 ng of total RNA with high quality, and the results 
demonstrated substantial amounts of amplified mRNA. In addition, the findings illustrated that the most 
amounts of mRNAs were obtained when the IVT reaction was fulfilled for 12 h. In this study, fresh tissue 
samples of ESCC patients were used as input source for RNA isolation and amplification. The results 
indicated that the amount and quality of the starting sample and also the reaction time of IVT can affect the 
quantity of generated mRNA. There is a close correlation between the initial concentration of used RNA and 
quantity of RNA obtained from amplification procedure[22].  
IVT fidelity can be determined through the comparative gene expression ratio, which is defined as 
unamplified in comparison to amplified RNA [23]. Here we compared the efficiency of generated mRNA via 
comparative real-time PCR versus total RNA. The expression level of described genes including MAGE-A4, 
CD44, XRCC5, SNAIL and OCT4, were obtained by real-time PCR using generated mRNA from IVT. In 
previous studies, expression level of these genes had also reported[2, 12-15]. Our results of real-time PCR 
were revealed that expression level of genes in amplified RNA was almost same with unamplified RNA. As 
a whole, our data have supported that the expression level of genes in transcripts generated by the SMART 
amplification approach are very similar. 
In conclusion, we demonstrated that mRNA amplification using the T7-based linear amplification method as 
a simple and rapid procedure was performed to generate considerable amount of RNA from a limited 
quantity of starting sample. The results of present study also showed similarity between the expression ratios 
of the examined genes in the amplified sample versus unamplified. Due to the low percentage of tumor tissue 
stem cells, this approach can be successfully applied for amplification of genes in cancer stem cells without 
change in their expression level.  
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